Erectile dysfunction drugs and skin cancer — should you worry?
By health.harvard.edu
A study published in JAMA Internal Medicine in 2014 found that men who used the erection-enhancing drug sildenafil (Viagra) were 84% more likely to develop melanoma, the most dangerous form of skin cancer, over a period of 10 years.
That finding makes for an attention-grabbing headline. But it’s also what I would call a true lie: a scientifically correct statement that could easily be misunderstood to mean “that little blue pill gives you deadly skin cancer.”
Here are two truths about this work that you need to know. 1) This study does not show that Viagra causes skin cancer. Instead, it shows that in a large group of men, those who said they used Viagra ended up being diagnosed more often with melanoma than those who didn’t use this drug. The study shows a connection, not a cause. 2). Even if Viagra does promote melanoma, the absolute increase is small.
I asked an expert in melanoma and skin cancer risk at Harvard-affiliated Massachusetts General Hospital, Dr. Hensin Tsao, what he thought of the study. He kindly shot back an email offering his perspective: “This is certainly a provocative study and warrants more careful replication. Several factors need to be considered.” Allow me to translate: The devil is in the details. The study is interesting but it does not mean that men should be worried—yet—that Viagra causes melanoma.
But they should definitely be worried about melanoma.
Risky business
The study grew out of laboratory research on how Viagra acts on cell-to-cell signaling pathways. This work demonstrated that the drug mimics key parts of a process that lets melanoma cells spread to other parts of the body. Skin cancer that spreads (metastasizes) is hard to control and can end in death.
To explore whether Viagra might have the same effect on melanoma in humans, a team of researchers looked at data collected from men taking part in the Health Professionals’ Follow-up Study, a project based at Harvard that began in 1986. The men filled out health and lifestyle questionnaires every two years. The questionnaire started asking men about use of erectile dysfunction drugs in 2000. In that year, 1,618 men reported having ever used Viagra.
Over the next decade, among the 29,929 men who said they had never used Viagra, 128 developed melanoma. Among the 1,618 Viagra users, 14 developed melanoma. In other words, 4.3 of every 1,000 who didn’t take Viagra developed melanoma compared to 8.6 of every 1,000 men who took Viagra.
After statistical adjustments, the increase from 4.3 to 8.6 is the 84% increase in risk that many news reports focused on. Researchers call that the relative risk (one group compared to another). The absolute increase, 4.3 cases per 1,000 men, represents an increase of 0.43%.
Whether a similar connection might exist between other erectile dysfunction drugs and melanoma isn’t known. In 2000, when the study was started, Viagra was the only erectile dysfunction drug on the market. Tadalafil (Cialis) and vardenafil (Levitra) weren’t approved until 2003, while avanafil (Stendra) came on the market in 2012.
How risky is that business?
The raw numbers suggest that the risk for melanoma associated with Viagra is small—one of the factors that Dr. Tsao said “need to be considered” when weighing the significance of the study. It’s even smaller than what was reported in the study because not all of the 14 cancers in the Viagra group can be attributed to the drug. Many factors affect a man’s risk of melanoma—the most important of which are age and cumulative exposure to ultraviolet (UV) radiation.
Should you worry?
Should men who use Viagra worry about getting melanoma? Right now, no one can say. The relationship could be pure coincidence. Epidemiological studies like this one tell you only who is at the scene of the crime, not who done it. The findings of the JAMA Internal Medicine study need to be replicated in other groups of men before sounding any warning bells.
In the meantime, Dr. Tsao offers some urgent advice to men: Protect your skin from too much sun and have routine skin checks to identify melanoma and other types of skin cancer early, while they are still treatable.
That’s especially important for older men, who are at greater risk for developing melanoma and also at greater risk for dying from it. An estimated 76,000 Americans (more than half of them men) will be diagnosed with melanoma this year, and almost 10,000 will die from it.
In short, be afraid—but not of Viagra. Be concerned about getting too much sun and pay attention to weird-looking moles that could turn into metastatic cancer. Cover up when you go outside, and use a broad-spectrum sunscreen liberally when you do go out into the sun to work and play.
Source: http://www.health.harvard.edu/blog/erectile-dysfunction-drugs-skin-cancer-worry-201406057197
what insurance covers cialis http://cialissom.com/ cialis und zeugungsfähigkeit cialis cheap cialis kaiser permanente cialis cheap differenza tra levitra e cialis http://cialisles.com/ sklep z cialis
Sunday, May 31, 2026
Levothyroxine (Synthroid) - Thyroid guide
Many patients do better with synthroid levothyroxine once they know what good follow through looks like outside clinic walls. This treatment is often chosen for patients replacing hormone after hypothyroidism or thyroid surgery. It usually works best when expectations stay practical. Follow up, correct timing, and early discussion of side effects matter as much as prescription itself. Clear background on this medicine appears at https://lucasclinic.com/thyroid/synthroid-levothyroxine/. Good reading does not replace clinical care, but it can make later conversations sharper by helping patients ask more precise questions about dose, timing, and monitoring. Consistency usually separates smooth treatment from frustrating treatment. Small habits such as taking medicine on schedule, checking refill dates early, and asking before mixing new products often make follow up visits more productive. Patients should also remember that treatment sits inside thyroid care, not in isolation. Sleep, diet, hydration, activity, and underlying conditions can shape how well plan works. That is why follow up visits should review whole pattern rather than one symptom in a vacuum. Follow through after prescription also matters. Refills should be planned before bottles run low, symptom notes should be brought to visits, and any major change in routine should be mentioned early. Many medication problems are easier to fix when clinician hears about them after first week of trouble rather than after several months of guessing. Side effects deserve plain discussion. Important warning signs may include palpitations, tremor, worsening anxiety, or ongoing fatigue despite treatment. Some effects are mild and temporary, while others need prompt review. Waiting too long because symptom seems embarrassing or inconvenient can delay needed changes in plan. Patients wanting wider perspective can use https://lucasclinic.com/thyroid/. Category pages often make it easier to understand how this medicine compares with related options and why clinicians sometimes switch plans over time. Strong outcomes usually come from small repeat actions: correct use, timely follow up, and fast response when body or schedule changes.
Thursday, May 28, 2026
HPV Vaccine: Protection Against Cancer-Causing Virus
Human papillomavirus is the most common sexually transmitted infection in the United States. While most HPV infections clear on their own without causing problems, persistent infection with certain high-risk strains causes most cases of cervical cancer and contributes to cancers of the oropharynx, anus, penis, vagina, and vulva. The HPV vaccine is one of the most powerful cancer prevention tools available, and vaccination before exposure provides the greatest benefit. Currently available HPV vaccines protect against the strains most commonly associated with cancer and genital warts. The 9-valent vaccine Gardasil 9 protects against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58. Types 16 and 18 are responsible for approximately 70 percent of cervical cancers. Types 6 and 11 cause 90 percent of genital warts. Broad coverage against multiple high-risk and low-risk strains maximizes protection. The HPV vaccine is recommended as a routine vaccine for all adolescents at age 11 or 12, with a two-dose schedule when started before age 15. Three doses are given when vaccination starts at age 15 or older. Vaccination is recommended through age 26 for anyone not previously vaccinated. Adults aged 27 to 45 may benefit from vaccination after discussion with their healthcare provider, though the benefit declines with increasing prior exposure to HPV. For health needs related to sexually transmitted infections and associated treatments, care is accessible through https://www.amoxilcompharm.com/. The HPV vaccine is safe and highly effective. Clinical trials demonstrated nearly 100 percent efficacy against the specific HPV types covered by the vaccine in individuals who had not previously been exposed. The vaccines do not contain live virus and cannot cause HPV infection. Common side effects are mild and include injection site soreness, dizziness, and low-grade fever. Even vaccinated individuals should continue recommended cervical cancer screening with Pap smears and HPV tests, as the vaccine does not protect against all cancer-causing HPV types and does not clear pre-existing infections. For comprehensive HPV vaccine information and preventive health resources, visit https://amoxicillina.online/ for evidence-based patient guidance.
Monday, May 18, 2026
Methotrexate For Lupus: Benefits, Dosage, And Safety
When a person is diagnosed with lupus or seeks relief from it, selecting the most appropriate medication requires weighing multiple factors: the severity of symptoms, the patient's age and health history, and whether other medications are already being taken. A thoughtful treatment choice improves outcomes and reduces unnecessary side effects. The spectrum of allergic disease is broad. Seasonal allergic rhinitis, often called hay fever, flares in response to outdoor allergens such as tree pollen in spring and ragweed in fall. Perennial allergies occur year-round and are typically triggered by indoor allergens like dust mites and pet dander. Chronic urticaria manifests as persistent hives and can last months or years without a clearly identifiable cause. All of these conditions share a common inflammatory pathway driven by the immune system's release of chemical mediators. Among the medications available for hormone therapy, Methotrexate provides a well-studied option that many patients discuss with their doctors. The clinical evidence supporting methotrexate for lupus shows that it can be effective for managing this condition when used appropriately under medical supervision. Methotrexate contains the active ingredient methotrexate, which works by acting on the biological pathways responsible for producing the symptoms associated with lupus. Understanding the mechanism helps patients appreciate why consistent use is often more effective than taking it only when symptoms become severe, as maintaining steady levels allows for more stable control. Patients managing lupus long-term should keep regular follow-up appointments to assess whether their treatment plan is still the best fit for their situation. As conditions change and new evidence emerges, treatment adjustments may be worthwhile. The hormone therapy resource section provides a helpful reference for staying current on medication options in this area.
Thursday, May 14, 2026
Using Generic Amoxicillin Augmentin to Treat Resistant Bacteria Infections and Maintain Treatment Confidence
Generic amoxicillin augmentin delivers identical resistant bacteria fighting capability to brand name Augmentin at substantially lower cost. Understanding generic equivalence removes hesitation and supports confident antibiotic choice when your healthcare provider prescribes this combination medication. Generic formulations undergo identical regulatory testing to confirm they deliver the same amount of amoxicillin and clavulanic acid as brand versions. Bioequivalence testing verifies that the combination works identically in body systems despite different manufacturing processes. This regulatory equivalence ensures therapeutic identity. Manufacturing standards for generic amoxicillin augmentin meet exact specifications matching brand production requirements. Quality control testing, sterility verification, and chemical purity assessments follow identical protocols. Regulatory oversight ensures no shortcuts compromise generic medication quality. Cost savings from generic amoxicillin augmentin result primarily from simplified production and distribution rather than compromised quality. Generic manufacturers bypass expensive brand research, development, and marketing costs. These operational efficiencies translate directly to lower consumer prices without reducing medication effectiveness. Insurance companies deliberately prefer generic amoxicillin augmentin formulations partly due to cost advantages and partly because millions of patients have documented successful outcomes. Extensive use history confirms reliable performance identical to brand versions. Some patients notice minor appearance differences between generic tablets and brand versions, including color, coating, or shape variations. These cosmetic differences result from different manufacturing methods but don't affect antibiotic strength or infection fighting capability. The active medication remains chemically identical. Switching between generic amoxicillin augmentin sources is completely safe. Different manufacturers might supply your prescriptions depending on pharmacy inventory availability. These switches maintain treatment effectiveness because the medication composition remains constant regardless of source. Family members taking generic amoxicillin augmentin from different manufacturers simultaneously poses no safety concerns. Each generic has undergone identical regulatory approval confirming therapeutic equivalence. Using multiple generic sources demonstrates healthcare system efficiency not quality variation. Your pharmacist can confirm dose strength and medication identity by checking bottle labeling against prescription details. Generic amoxicillin augmentin bottles display identical strength information as brand versions. Learn more about generic amoxicillin augmentin reliability and resistant bacteria treatment effectiveness by discussing generic versus brand choice with your healthcare provider. They can provide confidence that generic selection represents smart healthcare decision making without clinical compromise. Taking generic amoxicillin augmentin exactly as prescribed ensures you receive appropriate treatment for resistant bacteria despite cost savings. Generic status doesn't change dosing requirements, frequency, or total course duration necessary for complete infection clearance. Budget conscious patients often discover generic amoxicillin augmentin savings permit better overall healthcare investment. Money conserved on medication costs can support improved nutrition, household help during recovery, follow up appointments, or preventive healthcare services. Generic combination antibiotics represent the current standard of care for resistant bacteria infection treatment. Healthcare systems worldwide rely on generic amoxicillin augmentin because proven effectiveness, regulatory confidence, and affordability combine to provide optimal patient access. Concerns about generic medication quality sometimes reflect general medical anxiety rather than factual differences. Extensive clinical data demonstrates generic amoxicillin augmentin treats resistant bacteria identically to brand Augmentin. Choosing generic represents financially responsible decision making supported by comprehensive medical evidence. For evidence based information about resistant bacteria treatment and cost effective antibiotic decision making, explore reliable approaches to infection management. Generic amoxicillin augmentin offers patients proven infection treatment through regulated medications at accessible costs.
Monday, May 11, 2026
Understanding LDL Cholesterol Elevation and When Atorvastatin Therapy Becomes Necessary
Elevated LDL cholesterol remains one of the most modifiable risk factors for heart attack and stroke, and millions of people worldwide manage their cardiovascular risk through a combination of lifestyle changes and lipid-lowering medication. Understanding the clinical reasoning behind cholesterol treatment decisions helps patients make informed choices about long-term management. Low-density lipoprotein particles deposit cholesterol inside arterial walls over time, contributing to atherosclerotic plaques that narrow blood flow and raise cardiovascular risk. The higher the LDL level and the longer it remains elevated, the greater the cumulative arterial damage. This process happens without symptoms, which is why routine lipid screening catches problems before events occur. Treatment guidelines from cardiology societies address when medication becomes appropriate. Patients who have already experienced a heart attack, stroke, or significant coronary disease begin statin therapy regardless of initial LDL level because reducing cardiovascular events in this population is well established. These high-risk patients typically need aggressive LDL reduction to targets below seventy milligrams per deciliter. Primary prevention patients, those who have not yet had a cardiovascular event, enter the treatment equation based on a combination of LDL level, age, blood pressure, smoking history, diabetes status, and family history. Cardiovascular risk calculators help providers estimate ten-year event risk and determine whether the expected benefit from statin therapy outweighs any potential downsides. Lifestyle modification represents the foundation of cholesterol management before and alongside medication. A heart-healthy diet low in saturated fat, elimination of trans fats, increased dietary fiber from vegetables and whole grains, regular aerobic exercise, and weight management can each reduce LDL measurably. When these changes are insufficient to reach an LDL target aligned with a patient's cardiovascular risk, medication adds the required additional reduction. Atorvastatin, marketed as Lipitor, is among the most prescribed statins worldwide due to its proven cardiovascular outcome data from major clinical trials. The ASCOT-LLA and TNT trials demonstrated significant reductions in cardiac events for high-risk patients treated with atorvastatin at standard doses. Discussing lipitor atorvastatin for cholesterol management with a qualified provider helps patients understand whether their LDL level and overall risk profile make them appropriate candidates for statin therapy. Monitoring after starting atorvastatin includes a lipid panel at four to twelve weeks to assess treatment response. Liver enzyme monitoring, previously required routinely, is now recommended only for patients with symptoms suggesting liver involvement. Most patients tolerate atorvastatin without significant side effects at standard doses. Understanding that cholesterol treatment typically continues long-term helps patients mentally prepare for this commitment. Stopping therapy without medical guidance usually allows LDL to return to pretreatment levels within weeks. For comprehensive guidance on cholesterol treatment principles and medication options, exploring cardiovascular risk and cholesterol treatment resources builds the foundation for confident, informed medical conversations.
Thursday, May 7, 2026
Building a Consistent Scalp Care Routine for Recurrent Flaking
Recurrent scalp flaking can become difficult to manage when treatment is started and stopped repeatedly. Many people improve briefly, then relapse because routine factors were not adjusted or care was discontinued too soon. A consistent plan usually produces better long term control. The first step is defining a schedule that can be maintained during busy weeks. Irregular use, skipped wash days, and frequent product switching make it hard to judge response. A simple written plan helps patients stay consistent long enough to evaluate progress accurately. It is also important to minimize irritants during active treatment periods. Heavy styling products, harsh fragrances, and aggressive scratching can worsen inflammation and delay recovery. Gentle cleansing and careful scalp handling often improve comfort alongside treatment. Patients often research options while preparing for follow up. Reading about Nizoral-Ketoconazole can help frame practical questions on treatment duration, frequency, and warning signs that indicate reassessment. Monitoring progress with weekly notes can prevent unnecessary changes. Track itch level, visible scale, redness, and sleep disruption due to discomfort. These details make follow up discussions more precise and reduce guesswork. Hygiene habits beyond the scalp also matter. Regular cleaning of combs, hats, pillowcases, and shared grooming tools can reduce recurrent exposure pressure and support steadier improvement. Seek reassessment if symptoms spread quickly, pain increases, drainage appears, or fever develops. These patterns may indicate complications requiring additional care. For broader guidance on prevention and ongoing control, reviewing trusted information about antifungal management can support better outcomes. Lasting progress usually comes from accurate evaluation, disciplined routine use, and daily habits that reduce repeated irritation and reinfection risk. Families can support adherence by posting wash schedules and replacing shared hair accessories more frequently during active symptom periods each week at home consistently.
Subscribe to:
Posts (Atom)